Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q40403398)
Watch
English
Dynamics of chronic myeloid leukaemia.
scientific article published on June 2005
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
title
Dynamics of chronic myeloid leukaemia
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
main subject
leukemia
1 reference
based on heuristic
inferred from title
author
Yoh Iwasa
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
Martin A. Nowak
series ordinal
7
object named as
Martin A Nowak
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
Franziska Michor
series ordinal
1
object named as
Franziska Michor
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
author name string
Timothy P Hughes
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
Susan Branford
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
Neil P Shah
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
Charles L Sawyers
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
language of work or name
English
0 references
publication date
1 June 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
published in
Nature
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
volume
435
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
page(s)
1267-1270
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
issue
7046
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
exact match
https://scigraph.springernature.com/pub.10.1038/nature03669
0 references
cites work
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Purification and characterization of mouse hematopoietic stem cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A mutation conferring resistance to imatinib at the time of diagnosis of chronic myelogenous leukemia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Discontinuation of imatinib therapy after achieving a molecular response
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Imatinib mesylate-sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: report of two cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
DNA replication fidelity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overriding imatinib resistance with a novel ABL kinase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNATURE03669
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/NATURE03669
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
Dimensions Publication ID
1032868309
0 references
PubMed ID
15988530
1 reference
stated in
Europe PubMed Central
PubMed ID
15988530
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15988530%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
ResearchGate publication ID
7754569
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit